Chimeric transcript discovery by paired-end transcriptome sequencing
Open accessThe DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Abstract
Recurrent gene fusions are a prevalent class of mutations arising from the juxtaposition of 2 distinct regions, which can generate novel functional transcripts that could serve as valuable therapeutic targets in cancer. Therefore, we aim to establish a sensitive, high-throughput methodology to comprehensively catalog functional gene fusions in cancer by evaluating a paired-end transcriptome sequencing strategy. Not only did a paired-end approach provide a greater dynamic range in comparison with single read based approaches, but it clearly distinguished the high-level “driving” gene fusions, such as BCR-ABL1 and TMPRSS2-ERG , from potential lower level “passenger” gene fusions. Also, the comprehensiveness of a paired-end approach enabled the discovery of 12 previously undescribed gene fusions in 4 commonly used cell lines that eluded previous approaches. Using the paired-end transcriptome sequencing approach, we observed read-through mRNA chimeras, tissue-type restricted chimeras, converging transcripts, diverging transcripts, and overlapping mRNA transcripts. Last, we successfully used paired-end transcriptome sequencing to detect previously undescribed ETS gene fusions in prostate tumors. Together, this study establishes a highly specific and sensitive approach for accurately and comprehensively cataloguing chimeras within a sample using paired-end transcriptome sequencing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Over the last two years, with the further confirmation that the relatively short reads can be effectively assembled [15], especially with the great advantage of paired-end sequencing [54], the Illumina transcriptome or whole genome de novo sequencing and assembly have been successfully used for model [12,16,55-58]and non-model organisms [25-27,59].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696 · cited 1×
“Although current RNA sequencing (RNA-Seq) studies have been using 36-nt single reads (16, 17), we increased the likelihood of spanning a fusion junction by generating 100-nt long single reads using the Illumina Genome Analyzer II.”
MethodIdentification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439 · cited 1×
“However, the recent discovery of a recurrent gene fusion, TMPRSS2-ERG, in a majority of prostate cancers (5, 6), and EML4-ALK in non-small-cell lung cancer (NSCLC) (7), has expanded the realm of gene fusions as an oncogenic mechanism in common solid cancers.”
BackgroundRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationFive-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
A census of human cancer genes
Futreal, P. A., Coin, L., Marshall, M., Down, T., Hubbard, T., Wooster, R., Rahman, N., & Stratton, M. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1299 · Cited by 3,184 · cited 1×
“O of the most common classes of genetic alterations is gene fusions, resulting from chromosomal rearrangements (1).”
BackgroundEffects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
RNA-seq: An assessment of technical reproducibility and comparison with gene expression arrays
Marioni, J. C., Mason, C. E., Mane, S. M., Stephens, M., & Gilad, Y. (2008) · Genome Research · doi:10.1101/gr.079558.108 · Cited by 2,771
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Cited by
A survey of best practices for RNA-seq data analysis
Conesa, A., Madrigal, P., Tarazona, S., Gomez-Cabrero, D., Cervera, A., McPherson, A., Szcześniak, M. W., Gaffney, D. J., Elo, L. L., Zhang, X., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-0881-8 · Cited by 2,794
“Filtering highly polymorphic genes and pairs of homologous genes is recommended [86, 87].”
BackgroundRNA sequencing: advances, challenges and opportunities
Ozsolak, F., & Milos, P. M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2934 · Cited by 2,135
Advances in understanding cancer genomes through second-generation sequencing
Meyerson, M., Gabriel, S., & Getz, G. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2841 · Cited by 1,116
Prensner, J. R., Iyer, M. K., Balbin, O. A., Dhanasekaran, S. M., Cao, Q., Brenner, J. C., Laxman, B., Asangani, I. A., Grasso, C. S., Kominsky, H. D., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1914 · Cited by 1,029
Self-citationTopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Kim, D., & Salzberg, S. L. (2011) · Genome Biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 809
The emerging complexity of gene fusions in cancer
Mertens, F., Johansson, B., Fioretos, T., & Mitelman, F. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3947 · Cited by 682
Prensner, J. R., Iyer, M. K., Sahu, A., Asangani, I. A., Cao, Q., Patel, L., Vergara, I. A., Davicioni, E., Erho, N., Ghadessi, M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2771 · Cited by 669
Self-citationHaas, B. J., Dobin, A., Li, B., Stransky, N., Pochet, N., & Regev, A. (2019) · Genome biology · doi:10.1186/s13059-019-1842-9 · Cited by 646
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Palomero, T., Couronné, L., Khiabanian, H., Kim, M.-Y., Ambesi-Impiombato, A., Perez-Garcia, A., Carpenter, Z., Abate, F., Allegretta, M., Haydu, J. E., et al. (2014) · Nature Genetics · doi:10.1038/ng.2873 · Cited by 619
deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data
McPherson, A., Hormozdiari, F., Zayed, A., Giuliany, R., Ha, G., Sun, M. G. F., Griffith, M., Heravi Moussavi, A., Senz, J., Melnyk, N., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001138 · Cited by 557
“[9] demonstrated the capacity of RNA-Seq to find gene fusions in prostate cancer samples.”
BackgroundA new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion
Pierron, G., Tirode, F., Lucchesi, C., Reynaud, S., Ballet, S., Cohen-Gogo, S., Perrin, V., Coindre, J.-M., & Delattre, O. (2012) · Nature Genetics · doi:10.1038/ng.1107 · Cited by 478
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Palanisamy, N., Ateeq, B., Kalyana-Sundaram, S., Pflueger, D., Ramnarayanan, K., Shankar, S., Han, B., Cao, Q., Cao, X., Suleman, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2166 · Cited by 464
Self-citationUncovering the Complexity of Transcriptomes with RNA-Seq
Costa, V., Angelini, C., De Feis, I., & Ciccodicola, A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/853916 · Cited by 439
Wang, Z., Fang, B., Chen, J., Zhang, X., Luo, Z., Huang, L., Chen, X., & Li, Y. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-726 · Cited by 433
Advances in sarcoma genomics and new therapeutic targets
Taylor, B. S., Barretina, J., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3087 · Cited by 427
What can exome sequencing do for you?
Majewski, J., Schwartzentruber, J., Lalonde, E., Montpetit, A., & Jabado, N. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100223 · Cited by 394
The real cost of sequencing: higher than you think!
Sboner, A., Mu, X., Greenbaum, D., Auerbach, R. K., & Gerstein, M. B. (2011) · Genome Biology · doi:10.1186/gb-2011-12-8-125 · Cited by 372
Ren, S., Peng, Z., Mao, J.-H., Yu, Y., Yin, C., Gao, X., Cui, Z., Zhang, J., Yi, K., Xu, W., et al. (2012) · Cell Research · doi:10.1038/cr.2012.30 · Cited by 362
Next-generation sequencing in the clinic: Promises and challenges
Xuan, J., Yu, Y., Qing, T., Guo, L., & Shi, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.11.025 · Cited by 344
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer
Robinson, D. R., Kalyana-Sundaram, S., Wu, Y.-M., Shankar, S., Cao, X., Ateeq, B., Asangani, I. A., Iyer, M., Maher, C. A., Grasso, C. S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2580 · Cited by 340
Self-citationMaking sense of cancer genomic data
Chin, L., Hahn, W. C., Getz, G., & Meyerson, M. (2011) · Genes & Development · doi:10.1101/gad.2017311 · Cited by 336
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Edgren, H., Murumagi, A., Kangaspeska, S., Nicorici, D., Hongisto, V., Kleivi, K., Rye, I. H., Nyberg, S., Wolf, M., Borresen-Dale, A.-L., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-1-r6 · Cited by 316
Common Gene Rearrangements in Prostate Cancer
Rubin, M. A., Maher, C. A., & Chinnaiyan, A. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.1916 · Cited by 307
Self-citationIntegrative analysis of the melanoma transcriptome
Berger, M. F., Levin, J. Z., Vijayendran, K., Sivachenko, A., Adiconis, X., Maguire, J., Johnson, L. A., Robinson, J., Verhaak, R. G., Sougnez, C., et al. (2010) · Genome Research · doi:10.1101/gr.103697.109 · Cited by 305
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group
Reshmi, S. C., Harvey, R. C., Roberts, K. G., Stonerock, E., Smith, A., Jenkins, H., Chen, I.-M., Valentine, M., Liu, Y., Li, Y., et al. (2017) · Blood · doi:10.1182/blood-2016-12-758979 · Cited by 302
FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution
Ge, H., Liu, K., Juan, T., Fang, F., Newman, M., & Hoeck, W. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr310 · Cited by 280
ChimeraScan: a tool for identifying chimeric transcription in sequencing data
Iyer, M. K., Chinnaiyan, A. M., & Maher, C. A. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr467 · Cited by 276
Self-citationCancer transcriptome profiling at the juncture of clinical translation
Cieślik, M., & Chinnaiyan, A. M. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.96 · Cited by 269
Self-citationReis-Filho, J. S. (2009) · Breast Cancer Research · doi:10.1186/bcr2431 · Cited by 260
Next-generation sequencing to generate interactome datasets
Yu, H., Tardivo, L., Tam, S., Weiner, E., Gebreab, F., Fan, C., Svrzikapa, N., Hirozane-Kishikawa, T., Rietman, E., Yang, X., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1597 · Cited by 259
ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancer
Leeman‐Neill, R. J., Kelly, L. M., Liu, P., Brenner, A. V., Little, M. P., Bogdanova, T. I., Evdokimova, V. N., Hatch, M., Zurnadzy, L. Y., Nikiforova, M. N., et al. (2014) · Cancer · doi:10.1002/cncr.28484 · Cited by 257
The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression
Niknafs, Y. S., Han, S., Ma, T., Speers, C., Zhang, C., Wilder-Romans, K., Iyer, M. K., Pitchiaya, S., Malik, R., Hosono, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms12791 · Cited by 244
Self-citationKey Principles and Clinical Applications of “Next-Generation” DNA Sequencing
Rizzo, J. M., & Buck, M. J. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0432 · Cited by 238
Brunner, A. L., Beck, A. H., Edris, B., Sweeney, R. T., Zhu, S. X., Li, R., Montgomery, K., Varma, S., Gilks, T., Guo, X., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-r75 · Cited by 236
Chen, Y., Davidson, N., Wan, Y. K., Yao, F., Su, Y., Gamaarachchi, H., Sim, A., Patel, H., Low, H. M., Hendra, C., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02623-4 · Cited by 235
Evidence for Transcript Networks Composed of Chimeric RNAs in Human Cells
Djebali, S., Lagarde, J., Kapranov, P., Lacroix, V., Borel, C., Mudge, J. M., Howald, C., Foissac, S., Ucla, C., Chrast, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0028213 · Cited by 234
Design and validation issues in RNA-seq experiments
Fang, Z., & Cui, X. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr004 · Cited by 230
Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma
Moss, T. J., Qi, Y., Xi, L., Peng, B., Kim, T.-B., Ezzedine, N. E., Mosqueda, M. E., Guo, C. C., Czerniak, B. A., Ittmann, M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.05.048 · Cited by 226
Tian, Q., Price, N. D., & Hood, L. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02498.x · Cited by 224
Ferreira, P. G., Jares, P., Rico, D., Gómez-López, G., Martínez-Trillos, A., Villamor, N., Ecker, S., González-Pérez, A., Knowles, D. G., Monlong, J., et al. (2014) · Genome Research · doi:10.1101/gr.152132.112 · Cited by 214
The complexity of prostate cancer: genomic alterations and heterogeneity
Boyd, L. K., Mao, X., & Lu, Y.-J. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.185 · Cited by 214
Branford, S., Wang, P., Yeung, D. T., Thomson, D., Purins, A., Wadham, C., Shahrin, N. H., Marum, J. E., Nataren, N., Parker, W. T., et al. (2018) · Blood · doi:10.1182/blood-2018-02-832253 · Cited by 210
SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data
Jia, W., Qiu, K., He, M., Song, P., Zhou, Q., Zhou, F., Yu, Y., Zhu, D., Nickerson, M. L., Wan, S., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-2-r12 · Cited by 204
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
Pflueger, D., Terry, S., Sboner, A., Habegger, L., Esgueva, R., Lin, P.-C., Svensson, M. A., Kitabayashi, N., Moss, B. J., MacDonald, T. Y., et al. (2011) · Genome Research · doi:10.1101/gr.110684.110 · Cited by 201
Self-citationLevin, J. Z., Berger, M. F., Adiconis, X., Rogov, P., Melnikov, A., Fennell, T., Nusbaum, C., Garraway, L. A., & Gnirke, A. (2009) · Genome Biology · doi:10.1186/gb-2009-10-10-r115 · Cited by 195
Recurrent read-through fusion transcripts in breast cancer
Varley, K. E., Gertz, J., Roberts, B. S., Davis, N. S., Bowling, K. M., Kirby, M. K., Nesmith, A. S., Oliver, P. G., Grizzle, W. E., Forero, A., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3019-2 · Cited by 181
Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing
Kannan, K., Wang, L., Wang, J., Ittmann, M. M., Li, W., & Yen, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100489108 · Cited by 181
Zhao, L., Zhang, H., Kohnen, M. V., Prasad, K. V. S. K., Gu, L., & Reddy, A. S. N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00253 · Cited by 179
Pervasive transcription of the eukaryotic genome: functional indices and conceptual implications
Dinger, M. E., Amaral, P. P., Mercer, T. R., & Mattick, J. S. (2009) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/elp038 · Cited by 178
Veeraraghavan, J., Tan, Y., Cao, X.-X., Kim, J. A., Wang, X., Chamness, G. C., Maiti, S. N., Cooper, L. J. N., Edwards, D. P., Contreras, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms5577 · Cited by 176
Self-citationJAFFA: High sensitivity transcriptome-focused fusion gene detection
Davidson, N. M., Majewski, I. J., & Oshlack, A. (2015) · Genome Medicine · doi:10.1186/s13073-015-0167-x · Cited by 172
Translating cancer genomes and transcriptomes for precision oncology
Roychowdhury, S., & Chinnaiyan, A. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21329 · Cited by 168
Self-citationNacu, S., Yuan, W., Kan, Z., Bhatt, D., Rivers, C. S., Stinson, J., Peters, B. A., Modrusan, Z., Jung, K., Seshagiri, S., et al. (2011) · BMC Medical Genomics · doi:10.1186/1755-8794-4-11 · Cited by 167
Landscape of gene fusions in epithelial cancers: seq and ye shall find
Kumar‐Sinha, C., Sundaram, S. K., & Chinnaiyan, A. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0252-1 · Cited by 165
Self-citationLiu, S., Tsai, W.-H., Ding, Y., Chen, R., Fang, Z., Huo, Z., Kim, S., Ma, T., Chang, T.-Y., Priedigkeit, N. M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1234 · Cited by 162
Spliced synthetic genes as internal controls in RNA sequencing experiments
Hardwick, S. A., Chen, W. Y., Wong, T., Deveson, I. W., Blackburn, J., Andersen, S. B., Nielsen, L. K., Mattick, J. S., & Mercer, T. R. (2016) · Nature Methods · doi:10.1038/nmeth.3958 · Cited by 160
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
Sboner, A., Habegger, L., Pflueger, D., Terry, S., Chen, D. Z., Rozowsky, J. S., Tewari, A. K., Kitabayashi, N., Moss, B. J., Chee, M. S., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r104 · Cited by 159
Prostate Cancer Biomarkers: From diagnosis to prognosis and precision-guided therapeutics
Adamaki, M., & Zoumpourlis, V. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107932 · Cited by 157
Genome chaos: Survival strategy during crisis
Liu, G., Stevens, J. B., Horne, S. D., Abdallah, B. Y., Ye, K., Bremer, S. W., Ye, C., Chen, D. J., & Heng, H. H. (2013) · Cell Cycle · doi:10.4161/cc.27378 · Cited by 156
McCabe, M. S., Waters, S. M., Morris, D. G., Kenny, D. A., Lynn, D. J., & Creevey, C. J. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-193 · Cited by 156
Asmann, Y. W., Hossain, A., Necela, B. M., Middha, S., Kalari, K. R., Sun, Z., Chai, H. S., Williamson, D. W., Radisky, D. C., Schroth, G. P., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr362 · Cited by 152
Self-citationExisting and Emerging Technologies for Tumor Genomic Profiling
MacConaill, L. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5948 · Cited by 150
Chimeras taking shape: Potential functions of proteins encoded by chimeric RNA transcripts
Frenkel‐Morgenstern, M., Lacroix, V., Ezkurdia, I., Levin, Y., Gabashvili, A., Prilusky, J., del Pozo, Á., Tress, M. L., Johnson, R., Guigó, R., et al. (2012) · Genome Research · doi:10.1101/gr.130062.111 · Cited by 150
Riesgo, A., Andrade, S. C. S., Sharma, P. P., Novo, M., Pérez-Porro, A. R., Vahtera, V., González, V. L., Kawauchi, G. Y., & Giribet, G. (2012) · Frontiers in Zoology · doi:10.1186/1742-9994-9-33 · Cited by 142
Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives
Kim, J. H., Graef, A. J., Dickerson, E. B., & Modiano, J. F. (2015) · Veterinary Sciences · doi:10.3390/vetsci2040388 · Cited by 135
Identifying fusion transcripts using next generation sequencing
Kumar, S., Razzaq, S. K., Vo, A. D., Gautam, M., & Li, H. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1382 · Cited by 132
Chuang, T., Wu, C.-S., Chen, C.-Y., Hung, L.-Y., Chiang, T.-W., & Yang, M.-Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1013 · Cited by 130
Fusion genes and chromosome translocations in the common epithelial cancers
Edwards, P. A. (2010) · The Journal of Pathology · doi:10.1002/path.2632 · Cited by 126
“A popular implementation at the time of writing is to take 200–500 bp fragments of genome and, without cloning, sequence about 35 bp of each end, using the Illumina 1G sequencer [20,71].”
BackgroundMethodInfluentialWang, Q., Xia, J., Jia, P., Pao, W. J., & Zhao, Z. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbs044 · Cited by 126
Our changing view of the genomic landscape of cancer
Bell, D. W. (2009) · The Journal of Pathology · doi:10.1002/path.2645 · Cited by 130
Informatics for RNA Sequencing: A Web Resource for Analysis on the Cloud
Griffith, M., Walker, J. R., Spies, N. C., Ainscough, B. J., & Griffith, O. L. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004393 · Cited by 123
Tian, L., Li, Y., Edmonson, M. N., Zhou, X., Newman, S., McLeod, C., Thrasher, A., Liu, Y., Tang, B., Rusch, M., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02043-x · Cited by 123
Giacomini, C. P., Sun, S., Varma, S., Shain, A. H., Giacomini, M. M., Balagtas, J. M. S., Sweeney, R. T., Lai, E., Fitz, C. D. V., Forster, A. D., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003464 · Cited by 123
Opportunities and methods for studying alternative splicing in cancer with RNA-Seq
Feng, H., Qin, Z., & Zhang, X. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.010 · Cited by 121
New tricks from an old oncogene: Gene fusion and copy number alterations ofMYBin human cancer
Stenman, G., Andersson, M. K., & Andrén, Y. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12515 · Cited by 115
Wu, C.-S., Yu, C., Chuang, C.-Y., Hsiao, M., Kao, C.-F., Kuo, H., & Chuang, T. (2013) · Genome Research · doi:10.1101/gr.159483.113 · Cited by 108
CRAC: an integrated approach to the analysis of RNA-seq reads
Philippe, N., Salson, M., Commes, T., & Rivals, É. (2013) · Genome biology · doi:10.1186/gb-2013-14-3-r30 · Cited by 109
Heme and FLVCR-related transporter families SLC48 and SLC49
Khan, A. A., & Quigley, J. G. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.013 · Cited by 105
“SLC49A4 is predicted to have 12 TMD, a di-leucine motif in its N-terminus, and 2 potential tyrosine-based motifs in the C-terminus.”
BackgroundInfluentialFusionHunter: identifying fusion transcripts in cancer using paired-end RNA-seq
Li, Y., CHIEN, J. R., Smith, D. I., & Ma, J. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr265 · Cited by 103
An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer
Wang, X. S., Prensner, J. R., Chen, G., Cao, Q., Han, B., Dhanasekaran, S. M., Ponnala, R., Cao, X., Varambally, S., Thomas, D. G., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1584 · Cited by 102
Self-citationAsmann, Y. W., Necela, B. M., Kalari, K. R., Hossain, A., Baker, T. R., Carr, J. M., Davis, C., Getz, J. E., Hostetter, G. H., Li, X., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3142 · Cited by 100
Self-citationChimeric RNAs generated by intergenic splicing in normal and cancer cells
Jividen, K., & Li, H. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22207 · Cited by 99
Cytotoxicity and Transcriptomic Analysis of Silver Nanoparticles in Mouse Embryonic Fibroblast Cells
Gurunathan, S., Qasim, M., Park, C., Yoo, H., Choi, D. Y., Song, H., Park, C., Kim, J., & Hong, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113618 · Cited by 98
Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
Kangaspeska, S., Hultsch, S., Edgren, H., Nicorici, D., Murumägi, A., & Kallioniemi, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048745 · Cited by 100
JAFFAL: detecting fusion genes with long-read transcriptome sequencing
Davidson, N., Chen, Y., Sadras, T., Ryland, G. L., Blombery, P. A., Ekert, P. G., Göke, J., & Oshlack, A. (2022) · Genome biology · doi:10.1186/s13059-021-02588-5 · Cited by 96
Fusion genes and their discovery using high throughput sequencing
Annala, M., Parker, B. C., Zhang, W., & Nykter, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.011 · Cited by 96
Strand-specific deep sequencing of the transcriptome
Vivancos, A. P., Güell, M., Dohm, J. C., Serrano, L., & Himmelbauer, H. (2010) · Genome Research · doi:10.1101/gr.094318.109 · Cited by 96
De novo assembly and characterization of Camelina sativatranscriptome by paired-end sequencing
Liang, C., Liu, X., Yiu, S., & Lim, B. L. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-146 · Cited by 95
FusionCancer: a database of cancer fusion genes derived from RNA-seq data
Wang, Y., Wu, N., Liu, J., Wu, Z., & Dong, D. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0310-4 · Cited by 94
Global and unbiased detection of splice junctions from RNA-seq data
Ameur, A., Wetterbom, A., Feuk, L., & Gyllensten, U. (2010) · Genome Biology · doi:10.1186/gb-2010-11-3-r34 · Cited by 93
Gene-specific repression of the p53 target gene PUMA via intragenic CTCF–Cohesin binding
Gomes, N. P., & Espinosa, J. M. (2010) · Genes & Development · doi:10.1101/gad.1881010 · Cited by 92
Kumar, R. R., Goswami, S., SHARMA, S. K., Kala, Y. K., Rai, G. K., Mishra, D. C., Grover, M., Singh, G. P., Pathak, H. K., Rai, A. K., et al. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0097 · Cited by 85
Testing mutual exclusivity of ETS rearranged prostate cancer
Svensson, M. A., Lafargue, C. J., MacDonald, T. Y., Pflueger, D., Kitabayashi, N., Santa-Cruz, A. M., Garsha, K. E., Sathyanarayana, U. G., Riley, J., Yun, C. S., et al. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.179 · Cited by 81
Xie, C., Li, B., Xu, Y., Ji, D., & Chen, C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-107 · Cited by 81
Fusion Genes and RNAs in Cancer Development
Taniue, K., & Akimitsu, N. (2021) · Non-Coding RNA · doi:10.3390/ncrna7010010 · Cited by 81
Xu, D., Long, H., Liang, J., Zhang, J., Chen, X., Li, J., Pan, Z.-F., Deng, G., & Yu, M. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-133 · Cited by 79
Biomarkers for Prostate Cancer: From Diagnosis to Treatment
Chen, J., Wang, P., Liu, M., Lyu, F., Ma, M., Ren, X., & Gao, X. (2023) · Diagnostics · doi:10.3390/diagnostics13213350 · Cited by 78
Stricker, T. P., Catenacci, D. V. T., & Seiwert, T. Y. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.01.013 · Cited by 78
Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors
Reeser, J. W., Patacsil, D., Miya, J., Kautto, E. A., Lyon, E., Zhu, E. Y., Wing, M. R., Smith, A. M., Reeder, M., Samorodnitsky, E., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.05.006 · Cited by 78
Kumar, A., Gaur, V. S., Goel, A., & Gupta, A. K. (2014) · Plant Molecular Biology Reporter · doi:10.1007/s11105-014-0802-5 · Cited by 77
Metadata
- Authors
- Maher, C. A., Palanisamy, N., Brenner, J. C., Cao, X., Kalyana-Sundaram, S., Luo, S., Khrebtukova, I., Barrette, T. R., Grasso, C., Yu, J., Lonigro, R. J., Schroth, G., Kumar-Sinha, C., & Chinnaiyan, A. M.
- Affiliations
- Michigan Center for Translational Pathology (US)
- University of Michigan (US)
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109;
- Illumina (United States) (US)
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-07-28
- Volume
- 106
- Issue
- 30
- Pages
- 12353-12358
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2708976
- OpenAlex
- W2169810552
- Cited by
- 339
- References
- 29
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 15 · 2019: 13 · 2018: 11 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 27 · 2013: 41 · 2012: 49
- FWCI
- 17.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute on Drug Abuse (U54DA021519)
- National Cancer Institute (P50-CA-69568, R01CA132874, U01CA111275, K99CA129565, P50CA069568)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- gene fusion, fusion transcripts, BCR-ABL1, TMPRSS2-ERG fusion, ETS gene fusions, prostate cancer, cancer mutations
- MeSH terms
- Base Sequence, Humans, Male, Molecular Sequence Data, Neoplasms, Prostatic Neoplasms, RNA, Messenger, Transcription, Genetic, Oncogene Proteins, Fusion, Gene Expression Regulation, Neoplastic, Fusion Proteins, bcr-abl, Sequence Analysis, DNA, K562 Cells, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.